Year Founded
1993
Ownership
Public
Employees
~70
Therapeutic Areas
Women's HealthOncology
Stage
Commercial
Modalities
Medical devicesSmall moleculeMedical devices

Photocure General Information

Commercial stage company with Hexvix/Cysview for bladder cancer diagnosis and surveillance

Contact Information

Website
Primary Industry
[ "Diagnostics", "Biotech", "Pharma" ]
Corporate Office
Oslo,
Norway

Drug Pipeline

hexaminolevulinate
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Photocure's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Photocure Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Photocure's complete valuation and funding history, request access »